CSF3 and neutropenia: In our case, a wait‐and‐watch approach is deemed ideal, as neutropenia may resolve without medical intervention in young, healthy individuals, especially since G‐CSF was noted to have fatal complications when administered to post‐COVID‐19 neutropenic patients [17].